Status:
WITHDRAWN
Efficacy and Safety of Leningrado Association in the Treatment of Hypertension
Lead Sponsor:
EMS
Conditions:
Arterial Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of Leningrado association on the treatment of hypertension.
Eligibility Criteria
Inclusion
- Participants aged 18 years or more;
- Participants diagnosed with hypertension (mild to moderate), mild to moderate cardiovascular risk, not controlled by monotherapy and/ or lifestyle modification;
Exclusion
- Any clinical and laboratory findings that, in the judgment of the investigator, may interfere with the safety of research participants;
- BP ≥ 180/110 mmHg;
- Participants with BMI (body mass index) ≥ 40 Kg/m2;
- Previous diagnosis of secondary hypertension;
- History of taget organ damage;
- History of cardiovascular, hepatic and renal disease;
- History of gout, diabetes mellitus and hypokalemia;
- Current medical history of cancer;
- Current smoking;
- History of alcohol abuse or drug use;
- Pregnancy or risk of pregnancy and lactating patients;
- Known allergy or hypersensitivity to the medicines components used during the clinical trial;
- Participation in clinical trial in the year prior to this study.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03814109
Start Date
April 1 2022
End Date
January 1 2024
Last Update
July 27 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.